Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $48.52M.
ENTERPRISE VALUE (EV)
$48.52M
Cognition Therapeutics, Inc.
Market Cap
$85.02M
Enterprise Value (EV)
$48.52M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cognition Therapeutics, Inc. (CGTX) | $85.02M | $48.52M |
| Humacyte, Inc. (HUMA)vs › | $85.14M | $71.42M |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.24M | $91.89M |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | $45.45M |
| MediciNova, Inc. (MNOV)vs › | $83.92M | $58.62M |
| Conexeu Sciences Inc. (CNXU)vs › | $86.43M | N/A |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.09M | $78.35M |
| CareCloud, Inc. (CCLD)vs › | $87.75M | $128.37M |
| ImmuCell Corporation (ICCC)vs › | $88.04M | $91.63M |
| Citius Oncology, Inc. (CTOR)vs › | $81.82M | $75.47M |
Market Cap
$85.02M
Total Debt
$307000.00
Cash
$36.81M
Enterprise Value
$48.52M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
